Radiation blitz on early spread tumors could change breast cancer care
NCT ID NCT02089100
Summary
This study is testing if adding a highly focused, high-dose radiation treatment (called stereotactic body radiation therapy or SBRT) to standard first-line drugs can better control breast cancer that has recently spread to a few other body parts. It involves 154 patients whose cancer has spread to five or fewer locations. The goal is to see if this aggressive 'spot treatment' of the spread sites delays the cancer's progression and improves survival compared to drug treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU la Timone
Marseille, 13385, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
Centre de Cancérologie Paris Nord
Sarcelles, 95200, France
-
Centre de Radiothérapie de la Robertsau
Strasbourg, 67000, France
-
Georges François Leclerc
Dijon, 21079, France
-
Gustave Roussy Cancer Campus Grand Paris
Villejuif, Val de Marne, 94805, France
-
Henri Becquerel
Rouen, 76000, France
-
Hôpital Bretonneau
Tours, 37000, France
-
Hôpital Nord
Marseille, 13015, France
-
ICM - Val d'Aurelle
Montpellier, 34298, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut Sainte Catherine
Avignon, 84918, France
-
Institut de Cancérologie de l'Ouest
Saint-Herblain, 44805, France
-
Institut de cancérologie de l'Ouest René Gauducheau
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.